`
`From:
`Sent:
`To:
`Subject:
`
`Lauren Nowierski
`Thursday, August 27, 2015 10:31 AM
`Patti Green
`FW: Case IPR2015-01076 - Request for Conference Call re: Patent Owner's Request for
`Authorization to File Motion To Withdraw and Substitute Counsel
`
`
`
`From: Vignone, Maria [mailto:Maria.Vignone@USPTO.GOV] On Behalf Of Trials
`Sent: Wednesday, August 26, 2015 1:16 PM
`To: Lauren Nowierski; Trials
`Cc: jblake@merchantgould.com; jward@merchantgould.com; sbrunner@merchantgould.com;
`broutman@merchantgould.com; Paige Stradley (PStradley@MerchantGould.com); John Desmarais; Kevin McNish;
`Pharmacyclics IPR Service
`Subject: RE: Case IPR2015-01076 - Request for Conference Call re: Patent Owner's Request for Authorization to File
`Motion To Withdraw and Substitute Counsel
`
`Counsel: The request to file the motion to withdraw is authorized.
`Thank you,
`
`Maria Vignone
`Paralegal Operations Manager
`Patent Trial and Appeal Board
`571‐272‐4645
`
`
`
`From: Lauren Nowierski [mailto:LNowierski@desmaraisllp.com]
`Sent: Wednesday, August 26, 2015 12:12 PM
`To: Trials
`Cc: jblake@merchantgould.com; jward@merchantgould.com; sbrunner@merchantgould.com;
`broutman@merchantgould.com; Paige Stradley (PStradley@MerchantGould.com); John Desmarais; Kevin McNish;
`Pharmacyclics IPR Service
`Subject: Case IPR2015-01076 - Request for Conference Call re: Patent Owner's Request for Authorization to File Motion
`To Withdraw and Substitute Counsel
`
`
`
`Dear Sir or Madam:
`
`In Case IPR2015‐01076, Patent Owner Pharmacyclics LLC (“Pharmacyclics”) respectfully requests a conference call with
`the Board to seek authorization to file a motion to withdraw its current lead and back‐up counsel—John M. Desmarais,
`Kevin K. McNish, and Lauren M. Nowierski—and substitute Steven P. O’Connor (Reg. No. 41,225) and M. Paul Barker
`(Reg. No. 32,013) as lead and back‐up counsel, respectively, pursuant to 37 C.F.R. § 42.10(e).
`
`Good cause exists for withdrawal and substitution. Patent Owner will file a substitute power of attorney
`contemporaneously with its motion and does not request any extension of time. Petitioner’s counsel has been
`consulted and has stated it will not oppose the motion.
`
`
`1
`
`Pharmacyclics LLC - Ex. 2026
`Coalition for Affordable Drugs IV LLC v. Pharmacyclics LLC
`Case IPR2015-01076
`
`Exhibit 2026 Page 001
`
`
`
`The parties are available for a conference call with the Board on Monday August 31, 2015 and Tuesday, September 1,
`2015. Counsel for Petitioner is copied on this email.
`
`Best regards,
`Lauren Nowierski
`
`Lauren M. Nowierski
`Desmarais LLP
`230 Park Avenue
`New York, NY 10169
`212.351.3426 (direct) / 212.351.3401 (fax)
`
`
`
`This email may contain confidential and privileged material for the use of the intended recipient. Any review,
`use, or distribution by anyone other than the addressee is strictly prohibited. If you are not the intended
`recipient, please contact the sender by reply email and delete all copies of this message.
`
`2
`
`Exhibit 2026 Page 002
`
`